Back to top

Image: Bigstock

Company News for May 27, 2020

Read MoreHide Full Article
  • Shares of Evofem Biosciences, Inc. surged 16% after the clinical-stage biopharmaceutical company disclosed that the FDA had approved its birth control gel Phexxi.
  • Shares of Benefitfocus, Inc. soared 15.1% after the provider of cloud-based benefits management platform reported $80 million investment by BuildGroup LLC.
  • Shares of Sorrento Therapeutics, Inc. (SRNE - Free Report) rose 3.9% after the clinical stage biopharma company received FDA IND clearance to initiate Phase I clinical trial of its CD38 antibody-drug conjugate (ADC) STI-6129.
  • Shares of Cellectar Biosciences, Inc. (CLRB - Free Report) gained 7.1% after it received FDA fast track designation for CLR 131 in Lymphoplasmacytic Lymphoma and Waldenstrom's Macroglobulinemia.

See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Cellectar Biosciences, Inc. (CLRB) - free report >>

Sorrento Therapeutics, Inc. (SRNE) - free report >>

Evofem Biosciences, Inc. (EVFM) - free report >>

Published in

medical